Advertisement

Insect Sting Allergy

  • Robert E. Reisman
Chapter
  • 106 Downloads
Part of the Current Clinical Practice book series (CCP)

Abstract

Allergic reactions to insect stings are very common, and occasionally, a serious medical problem. The incidence of anaphylaxis in the general population has been estimated to range from 0.3 to 3%. Vital statistic registry data document at least 40 deaths/yr as a result of insect sting anaphylaxis with the likelihood that other episodes of unexplained sudden death are also the result of insect stings. Individuals at risk are often very anxious about further stings and, as a result, make significant changes in their life-styles.

Keywords

Skin Test Positive Skin Test Unexplained Sudden Death Negative Skin Test Insect Sting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. American Academy of Allergy, Asthma and Immunology Position Statement. Report from the Committee on Insects. JAllergy Clin Immunol 1998; 101: 573–575.CrossRefGoogle Scholar
  2. DeShazo RD, Butcher BT, Banks WA. Reactions to the stings of the imported fire ant. N Engl J Med 1990; 313: 462–466.Google Scholar
  3. Golden DBK, Kwiterovich KA, Kagey-Sobotka A, Lichtenstein LM. Discontinuing venom immunotherapy: Extended observations. J Allergy Clin Immunol 1998; 101: 298–305.PubMedCrossRefGoogle Scholar
  4. Lerch E, Müller UR. Long-term protection after stopping venom immunotherapy; Results of re-stings in 200 patients. J Allergy Clin Immunol 1998; 101: 606–612.PubMedCrossRefGoogle Scholar
  5. Lockey RF, Turkeltaub PC, Bair-Warren IA, et al. The Hymenoptera venom study I, 1979–1982: Demographics and history sting data. JAllergy Clin Immunol 1988; 82: 370–381.CrossRefGoogle Scholar
  6. Mauriello PM, Barde SH, Georgitis JW, Reisman RE. Natural history of large location reactions from stinging insects. J Allergy Clin Immunol 1984; 74: 494–498.PubMedCrossRefGoogle Scholar
  7. McKenna WR. Killer bees: what the allergist should know. Pediatr Asthma Allergy Immunol 1992; 4: 275–285.CrossRefGoogle Scholar
  8. Reisman RE. Natural history of insect sting allergy: Relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions. J Allergy Clin Immunol 1992; 90: 335–339.PubMedCrossRefGoogle Scholar
  9. Reisman RE. Venom hypersensitivity J Allergy Clin Immunol 1994; 94: 651–658.PubMedCrossRefGoogle Scholar
  10. Reisman RE, Livingston A. Venom immunotherapy; 10 years of experience with administration of single venoms and 50 mcg maintenance doses. JAllergy Clin Immunol 1992; 89: 1189–1195.CrossRefGoogle Scholar
  11. Valentine MD, Schuberth KC, Kagey-Sobotka A, et al. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1991; 323: 1601–1603.CrossRefGoogle Scholar
  12. van Halteren HK, van der Linden PWG, Burgers JA, Bartelink AKM. Discontinuation of yellow jacket venom immunotherapy. Follow up of 75 patients by means of deliberate sting challenge. J Allergy Clin Immunol 1997; 100: 767–770.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Robert E. Reisman

There are no affiliations available

Personalised recommendations